HIV Flashcards
(22 cards)
What’s the family and subgroup of HIV?
And what are the types of HIV?
- Family: Retroviridae
- Subgroup: Lentivirus
-
Types:
- HIV-1: Global; dominant
- HIV-2: Mainly West Africa
What’s the Structure & Genome & Accessory
- Envelope glycoproteins: gp120 (binds CD4), gp41 (fusion)
-
Structural genes:
-
env
: gp120, gp41 -
gag
: p24 (capsid), p17 (matrix) -
pol
: reverse transcriptase, integrase, protease
-
-
Regulatory/Accessory genes:
-
Essential:
tat
,rev
-
Accessory:
nef
,vif
,vpr
,vpu
-
Essential:
What are the Serotypes & Subtypes of HIV
-
HIV-1 groups: M (main), N, O, P
- Group M has 10 subtypes (A–J)
- HIV-2 groups: A–H (limited to West Africa)
Whats the mode of transmission & Risk per exposure
Transmission Modes (Global %)
- Sexual: 75% (vaginal > anal > oral)
- Mother-to-child: 10%
- IV drug use: 10%
- Blood transfusion: 5%
- Needlestick: <0.5%
Risk per exposure
- Transfusion: 90–95%
- Mother-child: 20–40%
- IV drug: 0.5–1%
- Needlestick: 0.3%
-
Sexual:
- Anal: 0.065–0.5%
- Vaginal: 0.05–0.1%
- Oral: 0.005–0.1%
What’s the pathogenesis?
Pathogenesis
- Step 1: gp120 binds CD4 on host cells
- Step 2: Requires co-receptors CCR5 (macrophage-tropic) or CXCR4 (T-cell-tropic)
- Step 3: Fusion ⏩ Reverse transcription ⏩ dsDNA
- Step 4: Integration via integrase ⏩ forms provirus
- Latency: Virus can still replicate & infect others
What are the Cells Infected?
Cells Infected
- CD4+ T cells
- Monocytes/macrophages
- Langerhans cells
- Astrocytes, glial cells
- Keratinocytes
What are the Stages of Disease Progression in
Stages of Disease Progression
-
Acute Retroviral Syndrome
- Flu-like illness, high viral load
-
Asymptomatic Stage
- Latent, slow CD4 decline
- Persistent Generalized Lymphadenopathy (PGL)
-
Symptomatic HIV (ARC)
- Opportunistic infections begin
-
AIDS
- CD4 <200 cells/mm³ or AIDS-defining illness
What are the **WHO Clinical Staging of HIV/AIDS (Adults) **
**WHO Clinical Staging of HIV/AIDS (Adults) **
Stage 1
- Asymptomatic
- Persistent generalized lymphadenopathy
Stage 2
- Unexplained moderate weight loss (<10%)
- Recurrent upper respiratory tract infections (sinusitis, tonsillitis, otitis media, pharyngitis)
- Herpes zoster
- Angular cheilitis
- Recurrent oral ulcers
- Papular pruritic eruptions
- Seborrheic dermatitis
- Fungal nail infections
Stage 3
- Unexplained severe weight loss (>10%)
- Unexplained chronic diarrhea >1 month
- Unexplained persistent fever >1 month
- Oral candidiasis
- Oral hairy leukoplakia
- Pulmonary TB
- Severe bacterial infections
- Acute necrotizing ulcerative gingivitis/stomatitis/periodontitis
- Unexplained anemia, neutropenia, or chronic thrombocytopenia
Stage 4 (AIDS)
HIV wasting syndrome:
> > 10% weight loss + chronic diarrhea or prolonged fever (>1 month)
Bacterial Infections
- Recurrent severe bacterial infections
- Extrapulmonary TB
- Disseminated nontuberculous mycobacteria
- Recurrent septicemia (e.g. nontyphoidal Salmonella)
Viral Infections
- Chronic herpes simplex ulcers (>1 month)
- CMV (retinitis or other organs, excluding liver/spleen/LNs)
- Progressive multifocal leukoencephalopathy (PML)
Fungal Infections
- Pneumocystis jirovecii pneumonia (PCP)
- Esophageal candidiasis
- Extrapulmonary cryptococcosis (e.g. meningitis)
- Disseminated mycoses (e.g. histoplasmosis, coccidioidomycosis)
Parasitic Infections
- Toxoplasma encephalitis
- Chronic intestinal isosporiasis or cryptosporidiosis (>1 month)
- Atypical disseminated leishmaniasis
Neoplasms
- Kaposi’s sarcoma
- Invasive cervical cancer
- Lymphomas (CNS, B-cell, non-Hodgkin)
Other
- HIV encephalopathy
- HIV-associated nephropathy or cardiomyopathy
What are the Laboratory Diagnosis of HIV
Laboratory Diagnosis of HIV
Screening Tests (Antibody detection)
- ELISA (2–3 hrs)
- Rapid tests (<30 min)
Supplemental (Antibody Detection)
- Western blot
- Immunofluorescence assay
- RIPA
- Line immunoassay (LIA)
Confirmatory Tests
- p24 antigen detection
-
HIV RNA detection (best method)
- RT-PCR
- Real-time PCR (viral load)
- Branched DNA assay
- NASBA
- HIV DNA detection (for pediatric HIV)
- Viral culture (co-cultivation)
Non-specific Immunologic Markers
- Low CD4 T-cell count
- CD4:CD8 ratio altered
- Hypergammaglobulinemia
- Raised neopterin, β2-microglobulin
Clinical diagnosis
Two such systems are currently in use:
CDC classification system (revised 1993) based on associated clinical conditions and CD4 T-cell count of the patient
WHO clinical staging of HIV/AIDS for adults (revised 2007) is based only on the clinical conditions.
What are the Tools used to monitor response to ART:
What are the Tools used to monitor response to ART:
- CD4 T-cell count: Most commonly used
- HIV RNA viral load: Most reliable and consistent tool
- p24 antigen: Less commonly used
What are the Goals of ART TREATMENT OF HIV/AIDS
- Clinical: Reduce symptoms, prevent opportunistic infections
- Virological: Suppress viral load
- Immunological: Restore/maintain immune function
- Transmission: Reduce risk of transmission
List the Antiretroviral Drugs (ARVs)
Class, Example & Function
Antiretroviral Drugs (ARVs)
Class Examples Function
NRTIs (Nucleoside Reverse Transcriptase Inhibitors) | Zidovudine, Lamivudine, Stavudine, Didanosine, Emtricitabine, Abacavir | Inhibit reverse transcription by being incorporated into viral DNA |
| NtRTIs (Nucleotide RTIs)
| PIs (Protease Inhibitors) | Ritonavir, Lopinavir, Saquinavir, Indinavir, Atazanavir, Darunavir, Fosamprenavir, Tipranavir | Inhibit viral protease enzyme
| Fusion Inhibitor | Enfuvirtide | Blocks virus entry into cell |
| Integrase Inhibitors | Dolutegravir, Raltegravir | Inhibit viral genome integration |
| CCR5 Receptor Inhibitor | Maraviroc | Blocks viral entry via CCR5 |
| Pharmacokinetic Booster | Cobicistat | Inhibits liver enzymes to boost other drugs |
Tenofovir | Similar to NRTIs
| NNRTIs (Non-Nucleoside RTIs) | Nevirapine, Efavirenz, Etravirine, Delavirdine, Rilpivirine
Bind directly to reverse transcriptase
What’s HAART (Highly Active Antiretroviral Therapy)
Why it’s used & Lines of treatment
HAART (Highly Active Antiretroviral Therapy)
- Combines ≥3 drugs to prevent resistance and suppress virus effectively.
First-Line Regimen (Adults & Adolescents)
Preferred:
- TDF + 3TC (or FTC) + DTG ⏩ e.g. TLD regimen
Alternatives:
- TAF + 3TC + DTG
- ABC + 3TC + DTG
- AZT + 3TC + EFV (400 mg)
Second-Line Regimen
Used when first-line fails due to resistance or side effects.
Preferred:
- AZT + 3TC + ATV/r or LPV/r
Alternatives:
- TDF + 3TC + DTG
- AZT + 3TC + DRV/r
- Double-dose LPV/r for TB-HIV coinfection
- DTG dose doubled (50 mg BID) with rifampicin
Special Conditions
What’s IRIS (Immune Reconstitution Inflammatory Syndrome)
Special Conditions
IRIS (Immune Reconstitution Inflammatory Syndrome)
- Occurs after starting ART.
- Recovered immunity reacts aggressively to hidden infections.
- Paradoxical worsening of symptoms.
How do you perform PEP (Post-Exposure Prophylaxis)?
PEP (Post-Exposure Prophylaxis)
- For needle stick or mucosal exposure.
- Start within 2 hours (maximum window = 72 hours).
- Regimen: TLD once daily for 28 days
How’s PMTCT (Prevention of Mother-to-Child Transmission) done?
PMTCT (Prevention of Mother-to-Child Transmission)
4 Pillars:
- Prevent HIV in women of reproductive age
- Prevent unintended pregnancies in HIV+ women
- Prevent transmission from HIV+ mothers to infants
- Provide care/support for mothers, infants, families
PMTCT (Prevention of Mother-to-Child Transmission)
What are the Package of Services for Mothers
PMTCT (Prevention of Mother-to-Child Transmission)
Package of Services for Mothers
- ART for all HIV-positive women
- Cotrimoxazole prophylaxis
- TB screening, prophylaxis, and treatment
- Infant feeding counselling and support
- Nutritional counselling and support
- Sexual and reproductive health services (incl. family planning)
- Cervical cancer screening
- Psychosocial support
- Partner counselling and testing
- PrEP for HIV-negative partners in serodiscordant couples
PMTCT (Prevention of Mother-to-Child Transmission)
Package of Services for HIV-Exposed Infants
PMTCT (Prevention of Mother-to-Child Transmission)
Package of Services for HIV-Exposed Infants
- ARV prophylaxis
- Routine immunization, growth monitoring, and support
- Cotrimoxazole prophylaxis starting at 6 weeks
-
HIV testing:
-
Virologic testing (DNA-PCR or NAT) at:
- Birth (if available)
- 6–8 weeks of age
- 6 weeks after breastfeeding ends
-
HIV antibody test:
- For children >9 months (if no virologic test available)
- Confirmatory diagnostic at >18 months
-
Virologic testing (DNA-PCR or NAT) at:
- Infant feeding counselling
- TB screening and treatment
- Malaria prevention and treatment
- Nutritional support
What are the ARV Prophylaxis for HIV-Exposed Infants? & Cotrimoxazole Prophylaxis for HIV-Exposed Infants
ARV Prophylaxis for HIV-Exposed Infants
- Start within 72 hours of birth
Risk Status ARV Prophylaxis Regimen Duration
| High risk | AZT (twice daily) + NVP (once daily) | 12 weeks |
Cotrimoxazole Prophylaxis for HIV-Exposed Infants
- Start at 6 weeks of age
-
Continue until HIV infection is ruled out
- Use age-appropriate test done 8–12 weeks after breastfeeding ends
Low risk | NVP once daily | 6 weeks |
What are the HIV Vaccine Challenges?
Why no effective vaccine yet?
- High mutability of HIV
- Long latent period before symptoms appear
- Lack of ideal animal models for preclinical studies